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INTRODUCTION
Acute liver injury induced by acetaminophen (also known as paracetamol, or APAP) is common in both humans and experimental animal models after ingestion of an overdose of the drug (McGill et al., 2012) . It is the most common agent of intentional self-harm and acetaminophen poisoning claimed the lives of 284 people aged 12 years and over between [1993] [1994] [1995] [1996] in England and Wales, UK (Hawton et al., 2004) . In addition, about 50 % of acute liver failure admitted cases in the United States of America are caused by acetaminophen poisoning (Larson et al., 2005) . Acetaminophen is metabolized in the liver and hepatotoxic metabolites that represents about 10 % of the whole metabolites are rapidly inactivated by glutathione (GSH) to protect the hepatocytes (James et al., 2003) . With drug overdose for example, the elevated levels of liver toxic metabolites, mainly N-acetyl-p-benzoquinoimine (NAPQI) rapidly deplete GSH and covalently modify cellular proteins leading to the generation of high levels of reactive oxygen species (ROS) and the depletion of the ATP, which results in mitochondrial damage and hepatocyte injury (Hinson et al., 2004) . However, it was postulated that depletion of 90 % of GSH in hepatocytes is critically necessary for the development of cell necrosis (Henderson et al., 2000) . In addition, hepatic inflammatory cytokines are also reported to be involved in acetaminophen-induced liver injury (Blazka et al., 1996) . However, dying hepatocytes (apoptosis pathway) upon hepatic injury induced by acetaminophen stimulate IL-11production, which supports compensatory proliferation of surrounding cells to maintain tissue hemostasis (Nishina et al., 2012) . Furthermore, acetaminophen modulated the apoptotic protein p53 and the survival protein SIRT1 cell signaling to promote hepatocyte proliferation (Wang et al., 2015) .
Quercetin and resveratrol are polyphenolic antioxidants found in fruits, vegetables, and grains (Cudmore et al., 2012) . They have been widely known to have potent cardiovascular protective and therapeutic effects via scavenging ROS (Hung et al., 2000) , anti-inflammatory effects (Rogerio et al., 2007; Al-Ani, 2013) , inhibiting lipid peroxidation (Frankel et al., 1993) , inhibiting platelet aggregation and thrombus formation (Bertelli et al., 1995) , prevention of apoptosis and promotion of cell survival (Singh et al., 2011) , and liver protection against hepatic sinusoidal obstruction and hepatic steatosis (Faghihzadeh et al., 2015; Zhang et al., 2017) . Therefore, this study was designed to investigate the degree of protection by resveratrol and quercetin given in combination against acetaminopheninduced apoptosis and to monitor oxidative stress levels and IL-11 in the presence and absence of resveratrol plus quercetin.
MATERIAL AND METHOD
Reagents and assay kits. Quercetin (C15H10O7, CAS Number 117-39-5) was purchased from Sigma-Aldrich (St. Louis, MO, USA) and was prepared daily and freshly by dissolving in normal saline solution (0.9 % NaCl) to the final concentration of 50mg/ml. Resveratrol (C14H12O3, Cat No. R5010) was also purchased from Sigma-Aldrich (St. Louis, MO, USA) and was prepared daily by dissolving in saline solution (0.9 % NaCl) containingg 20 % hydroxypropyl cyclodextrin (American Maize-Products Co., Hammond, IN, USA) to a final concentration of 30 mg/kg. Assay kits for determination of malondialdehyde (MDA, Cat No. NWK-MDA01) were purchased from NWLSS (Vancouver, BC, Canada). Superoxide dismutase (SOD, Cat. No. 706002) and glutathione peroxidase (GPx, Cat NO. 703102) activities were measured using commercial assay kits (Cat. No. 706002, Cayman Chemical, Ann Arbor, MI, USA). ELISA kits used for determining the levels of IL-6 and IL-11 were purchased from RayBio, GA, USA. Assay kits for determination of serum levels of ALT and AST were purchased from Human Co., Germany.
Animals. All experimental procedures were approved by the medical research ethical committee at King Khalid University and according to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH publication No.85-23, revised 1996) . Sprague Dawley rats (n=18) weighing 170-200 g were used in this study. All rats were bred and housed in the research center of King Khalid University, College of Medicine (Abha, Saudi Arabia), at temperatures of 23 ± 1 °C and a 12h light: 12h dark cycle. Rats had free access to tap water and fed standard laboratory chow during the acclimatization period.
Experimental design. After a one week adaptation period, rats were randomly assigned into 4 groups (n = 6; each) and were distributed in their corresponding cages and classified as follows: (1) Control group: rats received normal saline daily for 7 days; (2) RES+QUR group: rats were pre-treated with resveratrol (30 mg/kg) (Sener et al., 2006) and 50 mg/kg quercetin (Murota & Terao, 2003) FOR 7 days; (3) APAP intoxicated group (Model group): rats received normal saline for 7 consecutive days and then given a single dose of acetaminophen (2 g/kg, orally); and (4) RES+QUR+APAP group: rats were pre-treated with resveratrol and quercetin as above for 7 consecutive days and then administered with a single dose of acetaminophen (2 g/kg, orally). Acetaminophen was administered to the desired groups one hour after the last dose of treatment on day 7 and all treatment in all groups were administered i.p. in a final volume of 1 mL. All animals were sacrificed at day 8.
Blood samples.
At the end of the experimental period, blood samples were collected by cardiac puncture under anesthesia (sodium thiopentone at 40 mg/kg body weight) after an overnight fast of 12 hours. These blood samples were collected without any anticoagulant, left for 10 minutes, then centrifuged for 10 minutes at 4000 r/min to obtain serum, which was stored at minus 20 °C until further biochemical analysis for determination of serum liver injury enzymes ALT and AST according to manufacturer's instructions.
Preparation of liver homogenates. As we previously reported (Al Humayed, 2017), part of the livers obtained from the rats of all groups were freshly washed with phosphate buffered saline (PBS), pH 7.4. Then, they were homogenized with an ultrasonic homogenizer in cold phosphate buffer, pH 7.4, containing ethylene-diaminetetra-acetic acid (EDTA). The supernatant obtained from each rat was aliquot in separate tubes and stored at -70°C for later analysis of levels of Bcl-2, IL-11, IL-6, MDA, SOD, and GPx according to manufacturer's instructions.
Detection of p53 and Bax mRNAs by reverse transcriptase-polymerase chain reaction (RT-PCR).
Total RNAs were isolated from freshly dissected rats' livers using the RNeasy Mini Kit (Qiagen Pty, Victoria, Australia). The RNA was reverse-transcribed for a single strand cDNA synthesis (Invitrogen) and amplified by PCR using primer pairs for p53, Bax, and β-actin derived from the published cDNA sequence as previously described by our group (Eleawa et al., 2014) . The PCR products were separated by 2 % agarose gel electrophoresis and visualised by ethidium bromide, and gel images were scanned and quantified by densitometry using the NIH image software.
Histological study. Liver specimens were dissected out by midline laparotomy and immediately fixed in 10 % formol saline for 24 hours. Paraffin blocks were processed, sectioned in 5mm thickness and subjected to H&E staining to observe the morphological changes (Al-Hashem et al., 2019) .
Statistical analysis. The data were expressed as mean ± standard deviation (SD). Data were processed and analyzed using the SPSS version 10.0 (SPSS, Inc., Chicago, Ill., USA). One-way ANOVA was done followed by Tukey's post hoc test. Pearson correlation statistical analysis was performed for detection of a probable significance between two different parameters. Results were considered significant if p ≤ 0.05.
RESULTS
Induction of acute liver injury in rats by acetaminophen. The disease was induced in the model group of rats by acetaminophen overdose (2 g/kg body weight), which was confirmed 24 hours post acetaminophen ingestion as demonstrated by abnormal liver tissue architecture, a significant decrease in hepatic antioxidant, and a sharp increase in liver injury enzymes (Fig. 1) . Acetaminophen induced hepatotoxicity caused a twofold decrease in the levels of the antioxidant GPx (Fig. 1A) , and an increase in ALT (Fig. 1B, a fivefold increase) and AST (Fig. 1C , a sevenfold increase) compared to normal levels in the control group. H&E stained images of liver tissues from the model group revealed cytoplasmic vacuolation of hepatocytes, pericentral necrotic areas, infiltrating inflammatory cells, and haemorrhage ( Fig. 1E ) compared with a normal liver parenchyma in the control group (Fig. 1D ). Resveratrol plus quercetin augment tissue levels of antioxidants, and ameliorate blood levels of liver injury enzymes. To investigate the level of protection to the acetaminophen-induced modulation of these biomarkers by combined injections of resveratrol and quercetin for 7 days prior to acetaminophen hepatic intoxication, we measured SOD, GPx, ALT, and AST in all rat groups. Compared to the control group, acute liver injury induced by acetaminophen significantly (p<0.05) modulated SOD, GPx, ALT, and AST, which were completely protected by RES+QUR (Table I) Resveratrol plus quercetin protect acetaminophenmodulated the hepatic apoptosis and survival biomarkers. Apoptosis is triggered by a wide variety of stress and inflammatory stimuli (Yang et al., 2015) . We investigated in a rat model of acute liver injury induced by acetaminophen, whether resveratrol plus quercetin can modulate the apoptotic biomarker Bax and the antiapoptotic protein Bcl-2 that are located downstream of p53 in hepatocyte mitochondrial damage (Panasiuk et al., 2006) . Thus, we assessed the expression of messenger RNAs for p53 and Bax genes using RT-PCR, and also measured the levels of the survival protein Bcl-2 by ELISA. Acute liver injury induced by acetaminophen augmented p53 (13 fold) and Bax (15 fold) mRNA messages ( Fig. 2A-C) , and ameliorated Bcl-2 (3 fold) ( Fig. 2D ). Pre-treatment with resveratrol plus quercetin substantially inhibited p53 (about 70 % reduction; Fig. 2B) and Bax (about 70 % reduction; Fig. 2C ) gene expression, and significantly (p<0.0001) augmented Bcl-2 levels (Fig.  2D) . These agents increased Bcl-2 levels comparable with the control levels. Furthermore, a negative correlation between the antiapoptotic protein Bcl-2 scorning and the hepatic levels of apoptotic biomarkers was achieved; Bcl-2 versus p53 (r = -0.576; p=0.004) ( Fig. 2E) , and Bcl-2 versus Bax (r = -0.590; p=0.003) (Fig. 2F ).
Resveratrol plus quercetin reduce acetaminopheninduced biomarkers of oxidative stress and inflammation.
Oxidative stress induced acute liver injury in mice was reported to increase the production of IL-11 by apoptotic hepatocytes to promote the proliferation of healthy surrounding hepatocytes (Nishina et al.) . To determine whether the observed acetaminophen-induced apoptosis mentioned above is associated with the upregulation of oxidative stress biomarker and IL-11, which is a member of IL-6 pro-inflammatory family of cytokines, we measured liver tissue levels of MDA (Fig. 3A) , IL-6 ( Fig. 3B) , and IL-11 ( Fig. 3C ) in all animal groups. Acetaminophen significantly (p<0.05) increased these biomarkers, which were completely protected by resveratrol plus quercetin.
We further determined the correlation between IL-11 scoring and the hepatic levels of apoptotic and antiapoptotic biomarkers, and oxidative stress in order to further support the link between IL-11, apoptosis, and oxidative stress, and to confirm and characterize that the role of these agents (resveratrol and quercetin) are stable and appropriate agents in liver injury in rats. As shown in Fig. 4 , a positive correlation was scored between IL-11 scoring and these biomarkers ( Fig. 4A-C) except the antiapoptotic biomarker, Bcl-2 which showed as expected, a negative correlation (Fig. 4D) ; IL-11 versus p53 (r = 0.783; p<0.0001), IL-11 versus Bax (r = 0.781; p<0.0001), IL-11 versus MDA (r = 0.933; p<0.0001), and IL-11 versus Bcl-2 (r = -0.743; p<0.0001). Fig. 3 . Resveratrol and quercetin inhibit acetaminophen-induced MDA, IL-6, and IL-11 biomarkers in rats. Liver homogenates levels of MDA (A), IL-6 (B), and IL-11 (C) were measured at the end of the experiment in different groups of rats used in this study; Control group, RES+QUR group, APAP group, and RES+QUR+APAP group. Results represent the mean (±SD); n=6 for each group. Experiments were performed in triplicate. *p<0.05 versus control, **p<0.05 versus APAP. APAP: acetaminophen; QUR: quercetin; RES: resveratrol.
DISCUSSION
The principal findings in our study were that in a rat model of acute liver injury (i) acetaminophen induced hepatotoxicity modulated all the assessed biomarkers of cell death and survival; (ii) acetaminophen induced Fig. 4 . Correlation between IL-11 scoring and biomarkers of apoptosis, survival, and oxidative stress. Liver IL-11 levels were assessed in all groups of rats one day post liver intoxication by acetaminophen and the correlation between IL-11 and p53, IL-11 and Bax, IL-11 and MDA, and IL-11 and Bcl-2 are shown in (A-D), respectively. IL-11: interleukin-11; p53: tumor suppressor p53; Bax: BCL2 associated X; MDA: malondialdehyde; Bcl-2: B-cell lymphoma 2.
hepatotoxicity augmented the pro-inflammatory cytokine IL-11 that provides a functional link between oxidative stress and apoptosis; and (iii) the polyphenolic antioxidant compounds resveratrol plus quercetin were almost completely protected against these hepatotoxicity induced by acetaminophen. These conclusions are supported by the data indicating that acetaminophen-induced acute liver injury (Fig. 1) caused modulation of p53, Bax, and Bcl-2 (Fig. 2) , and upregulation of IL-11 and MDA (Fig. 3 ) that were substantially protected by resveratrol plus quercetin (Figs.  2 and 3) . Also, our data that shows a positive correlation between IL-11 scoring and the liver tissue levels of p53, Bax, and MDA ( Fig. 4A -C) supports our conclusion mentioned above. Our results were thus consistent with our working hypothesis, which the combined polyphenolic compounds, resveratrol and quercetin can substantially protect against acetaminophen-induced hepatic apoptosis in rats, which is associated with the inhibition of IL-11 and MDA.
Oxidative stress and inflammation are known to be involved in the pathology of acute liver injury in animal models and humans (Jaeschke et al., 2014) , and the proinflammatory cytokine IL-11 that is mainly produced by dying hepatocytes upon acute liver injury was reported to provide a functional link between oxidative stress and compensatory hepatocyte proliferation (Nishina et al.) . In addition, resveratrol was reported to inhibit p53 and augment the survival protein SIRT1 cell signaling to promote hepatocyte proliferation in mice treated with acetaminophen overdose (Wang et al.) . These reports are in agreement with our findings of elevated levels of p53, Bax, IL-11, and MDA in acetaminophen-induced acute liver injury, which were protected with resveratrol plus quercetin. Also, our data is in agreement with another study showing acetaminophen overdose induced apoptosis in liver cancer derived cells, human hepatoma cell line, and overexpression of the antiapoptotic protein Bcl inhibited apoptosis (Boulares et al., 2002) .
Our protective approach by pre-treatment with a combination of two antioxidants that almost completely blocked the damaging effects of acetaminophen-induced hepatotoxicity, which were also associated with the suppression of major tissue injury biomarkers, highlight the potential efficacy of resveratrol plus quercetin in controlling, for example, liver injury complications which can arise from the requirement of administering high doses of acetaminophen for a long period of time to patients with chronic illnesses in order to continuously replenish the body with antioxidants that detoxify NAPQI. Indeed, the adverse effects of acetaminophen can be ameliorated by the antioxidant N-acetylcysteine (NAC), which increases GSH and detoxifies NAPQI (Prescott et al., 1977) .
In summary, these studies support the conclusion that apoptotic pathway and IL-11 are involved in the pathogenesis of acetaminophen-induced acute liver injury in a rat model of the disease, and resveratrol plus quercetin substantially protects against acetaminophen hepatotoxicity.
